Presage, Celgene ally to identify new drug combos for solid tumor

Presage Biosciences and Celgene entered into a research alliance to find new drug combinations for solid tumors. Presage will get $5 million upfront, $8 million in equity investment plus potential future payments.

View Full Article in:

American City Business Journals · Genetic Engineering & Biotechnology News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
In house Compliance Officer
Confidential
Pompano Beach, FL
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Director, Site Quality Management
CareFusion
Palm Springs, CA